Skip to main content
. 2020 Sep 28;11(6):1830–1849. doi: 10.1002/jcsm.12612

Table 1.

Primer sequences

GenBank accession # Forward primer Reverse primer
MuRF1 NM_080903.1 CTCCTTGTGCAAGGTGTTCG AGTCTGAACTCGGTCGTTCC
Atrogin‐1 NM_133521.1 AGCTTGTGCGATGTTACCCA GGTGAAAGTGAGACGGAGCA
Myostatin NM_019151.1 TATCACGCTACCACGGAAACAA ATCCACAGCTGGGCCTTTAC
PGC‐1α NM_031347.1 CCGAGAATTCATGGAGCAAT GTGTGAGGAGGGTCATCGTT
IGF‐1 NM_001082477.2 GGACGCTCTTCAGTTCGTGT GATCACAGCTCCGGAAGCAA
IL‐1β NM_031512.2 CTATGTCTTGCCCGTGGAGC CGTCATCATCCCACGAGTCA
IL‐6 NM_012589.2 CACAAGTCCGGAGAGGAGAC TCTGACAGTGCATCATCGCT
TNF‐α NM_012675.3 TGATCCGAGATGTGGAACTGG CGATCACCCCGAAGTTCAGTA
AT1 NM_030985.4 CCCACTCAAGCCTGTCTACG CTGGCTTCTGTCAGGGCATTA
AT2 NM_012494.3 TTTGCCATCCTCCTGGGATT GCCTTGGAGCCAAGTAATGG
18S rRNA NR_046237 GTTGGTGGAGCGATTTGTCTG GCTCAATCTCGGTGGCTGA

AT1, angiotensin II receptor type 1; AT2, angiotensin II receptor type 2; IGF‐1, insulin‐like growth factor 1; IL, interleukin; MuRF1, muscle‐specific RING finger 1; PGC‐1α, peroxisome proliferator‐activated receptor‐γ coactivator 1α; TNF‐α, tumour necrosis factor‐α.